Idexx Laboratories Inc /DE SEC filings IDXX
Idexx Laboratories Inc /DE has 1,005 filings in SEC EDGAR's recent list, going back to Feb 9, 2015. Its latest annual report, Form ARS, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Mar 27, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Feb 20, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Mar 28, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Feb 21, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Mar 27, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 22, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Mar 31, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 16, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 16, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Feb 12, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Feb 14, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Feb 15, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Feb 16, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Feb 17, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Feb 17, 2016 | Dec 31, 2015 |
| ARS | Annual report to shareholders | Mar 25, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Feb 17, 2015 | Dec 31, 2014 |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- IDXX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Westbrook, ME
- SEC filer status
- Large accelerated filer
- SEC CIK
- 874716
Other In Vitro & In Vivo Diagnostic Substances companies
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
- Alpha Teknova, Inc. TKNO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.